MStranslate logo
Log In
Lost your password?
Lost Password
Back to login
Search
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us
Breaking
  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • UPDATED: The ECTRIMS Podcast - Episode Library
  • Patient Community Day at ECTRIMS 2025
  • Multiple Sclerosis in 2025 – Key Developments to Date
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us

Lifestyle

Home
Lifestyle
Emily O'Kearney

Facebook Live: Diet Outcomes in Multiple Sclerosis

MStranslate
February 14, 2018
Community, Diet, Events, Lifestyle
2 Comments
On Tuesday 6th February, 2018, MStranslate had the pleasure of being joined by multiple sclerosis researcher, Ms Emily O'Kearney, for a Facebook Live event on the topic of "Diet Outcomes in Multiple...
exercise

Study Investigates Exercise Conditions for PwMS

MStranslate
January 12, 2018
Exercise, Lifestyle, Research
Research Summary: Environmental temperature and exercise modality independently impact central and muscle fatigue among people with multiple sclerosis Whilst more and more studies are suggesting that...
diet

Diet Quality is Important in Multiple Sclerosis

MStranslate
December 10, 2017
Diet, Lifestyle, Research
This year we have seen a large increase in the focus of research into how lifestyle factors may benefit people living with multiple sclerosis.  In particular, studies investigating the effect of diet in MS...
exercise

Exercise May Improve Brain Connectivity in PwMS

MStranslate
November 14, 2017
Exercise, Lifestyle, Research
There is growing evidence for the benefits of exercise for people with multiple sclerosis. Studies have shown that the advantages gained from regular physical activity can include decreasing fatigue, improving...
comorbidities

The Importance of Overall Health in Multiple Sclerosis

MStranslate
November 1, 2017
Lifestyle, Research
Thankfully, we are beginning to see an increased amount of research being conducted to examine the benefits of an overall health approach to the management of multiple sclerosis.  In particular, there is an...
lifestyle treatments

Do We Need Clinical Trials for MS Lifestyle Treatments?

MStranslate
August 30, 2017
Lifestyle, Opinion, Treatments
1 Comment
We have been discussing lifestyle factors, such as diet and exercise, a lot recently on MStranslate.  This has been presented both in terms of the reported benefits of these approaches from anecdotal evidence...
lifestyle

Alternative Treatment Approaches in MS Reviewed

MStranslate
August 29, 2017
Lifestyle, Research, Treatments
2 Comments
Across the last few weeks, the MStranslate Facebook page has placed a large focus on lifestyle modifications and how they can be used to help manage multiple sclerosis. As well as gauging how members of the MS...
vitamin D

Multiple Sclerosis, Vitamin D & Bone Health

MStranslate
July 24, 2017
Lifestyle, Research, Vitamin D
Research Summary: High dose vitamin D supplementation does not affect biochemical bone markers in multiple sclerosis - a randomised controlled trial There has been a lot of online coverage during the past two...
BMI

BMI & Lipid Levels Impact MS Progression

MStranslate
April 26, 2017
Diet, Lifestyle, Research
2 Comments
Research Summary: An adverse lipid profile and increased levels of adiposity significantly predict clinical course after a first demyelinating event An increasing emphasis is being placed on how lifestyle...
muscles

MS: Many Stories – From the MStranslate Community

MStranslate
February 26, 2017
Community, Exercise, Lifestyle, MS: Many Stories
Welcome to part 3 of a series of articles being written by MStranslate community member, Andrew.  You may remember Andrew from a video we featured in late 2016, introducing the potential benefits of pilates...
  1. 1
  2. 2
  3. 3
  4. 4

Recent Posts

  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • UPDATED: The ECTRIMS Podcast – Episode Library
  • Patient Community Day at ECTRIMS 2025

Recent Comments

  • FDA Decision On Tolebrutinib - MStranslate on Multiple Sclerosis in 2025 – Key Developments to Date
  • Treatment With Gut Bacteria Shows Benefits In New Study on Gut Bacteria in People Living with RRMS
  • Community Q&A: COVID-19 Vaccines & Multiple Sclerosis on Community Q&A: The Blood-Brain Barrier
  • Community Q&A: Why Don't We Have A Multiple Sclerosis Cure? on Community Q&A: COVID-19 Vaccines & MS
  • Tim Little on FAKE NEWS ALERT: COVID Vaccines & MS

Calendar

March 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
« Jan    

Archives

Categories

Posts

  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • UPDATED: The ECTRIMS Podcast – Episode Library
  • Patient Community Day at ECTRIMS 2025

Google+

Get social

Copyright 2014-2018 MStranslate. All Rights Reserved. Contact Us
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.